Quick Takeaways
- BIOTECHNOLOGY VALUE FUND L P filed SCHEDULE 13G/A for Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share (TYRA).
- Disclosed ownership: 7.8%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"BIOTECHNOLOGY VALUE FUND L P disclosed 7.8% ownership in Tyra Biosciences, Inc. Common Stock, $0.0001 par value per share (TYRA) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 4% | 2,032,310 | 0 | 2,032,310 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF I GP LLC | 4% | 2,032,310 | 0 | 2,032,310 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BIOTECHNOLOGY VALUE FUND II LP | 3.2% | 1,642,427 | 0 | 1,642,427 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF II GP LLC | 3.2% | 1,642,427 | 0 | 1,642,427 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| Biotechnology Value Trading Fund OS LP | 0.4% | 205,920 | 0 | 205,920 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF Partners OS Ltd. | 0.4% | 205,920 | 0 | 205,920 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF GP HOLDINGS LLC | 7.3% | 3,674,737 | 0 | 3,674,737 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF PARTNERS L P/IL | 7.8% | 3,944,194 | 0 | 3,944,194 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| BVF INC/IL | 7.8% | 3,944,194 | 0 | 3,944,194 | /s/ Mark N. Lampert | Mark N. Lampert, Authorized Signatory | |
| LAMPERT MARK N | 7.8% | 3,944,194 | 0 | 3,944,194 | /s/ Mark N. Lampert | Mark N. Lampert |